125 related articles for article (PubMed ID: 8302608)
1. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer.
Jolly KW; Malkin D; Douglass EC; Brown TF; Sinclair AE; Look AT
Oncogene; 1994 Jan; 9(1):97-102. PubMed ID: 8302608
[TBL] [Abstract][Full Text] [Related]
2. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ
Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
[TBL] [Abstract][Full Text] [Related]
3. p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.
Hartmann A; Blaszyk H; McGovern RM; Schroeder JJ; Cunningham J; De Vries EM; Kovach JS; Sommer SS
Oncogene; 1995 Feb; 10(4):681-8. PubMed ID: 7862445
[TBL] [Abstract][Full Text] [Related]
4. A novel p53 germline alteration identified in a late onset breast cancer kindred.
Sun XF; Johannsson O; Håkansson S; Sellberg G; Nordenskjöld B; Olsson H; Borg A
Oncogene; 1996 Jul; 13(2):407-11. PubMed ID: 8710380
[TBL] [Abstract][Full Text] [Related]
5. Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families.
Montagna M; Santacatterina M; Corneo B; Menin C; Serova O; Lenoir GM; Chieco-Bianchi L; D'Andrea E
Cancer Res; 1996 Dec; 56(23):5466-9. PubMed ID: 8968102
[TBL] [Abstract][Full Text] [Related]
6. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
8. A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer.
Gajalakshmi P; Natarajan TG; Selvi Rani D; Thangaraj K
Breast Cancer Res Treat; 2007 Jan; 101(1):3-6. PubMed ID: 17131039
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS
N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D; Jolly KW; Barbier N; Look AT; Friend SH; Gebhardt MC; Andersen TI; Børresen AL; Li FP; Garber J
N Engl J Med; 1992 May; 326(20):1309-15. PubMed ID: 1565144
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 germline mutations in Indian familial breast cancer.
Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
[TBL] [Abstract][Full Text] [Related]
12. Novel p53 splice site mutations in three families with Li-Fraumeni syndrome.
Verselis SJ; Rheinwald JG; Fraumeni JF; Li FP
Oncogene; 2000 Aug; 19(37):4230-5. PubMed ID: 10980596
[TBL] [Abstract][Full Text] [Related]
13. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
15. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
[TBL] [Abstract][Full Text] [Related]
16. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
[TBL] [Abstract][Full Text] [Related]
17. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.
Caligo MA; Ghimenti C; Cipollini G; Ricci S; Brunetti I; Marchetti V; Olsen R; Neuhausen S; Shattuck-Eidens D; Conte PF; Skolnick MH; Bevilacqua G
Oncogene; 1996 Oct; 13(7):1483-8. PubMed ID: 8875986
[TBL] [Abstract][Full Text] [Related]
19. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
Warneford SG; Witton LJ; Townsend ML; Rowe PB; Reddel RR; Dalla-Pozza L; Symonds G
Cell Growth Differ; 1992 Nov; 3(11):839-46. PubMed ID: 1467311
[TBL] [Abstract][Full Text] [Related]
20. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.
Claes K; Poppe B; Machackova E; Coene I; Foretova L; De Paepe A; Messiaen L
Genes Chromosomes Cancer; 2003 Jul; 37(3):314-20. PubMed ID: 12759930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
